GlassScriptPhysician profile
Daniel Lee Miller
NPI 1831288430
$236,684.30
in general payments reported to CMS, 2019-2025
34 companies · $18K in 2025
The $18K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $21K · 2021: $13K · 2022: $71K · 2023: $67K · 2024: $35K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $95K · Travel and Lodging: $17K · Food and Beverage: $4,868 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,083.29 |
| Travel and Lodging | $17,378.08 |
| Food and Beverage | $4,867.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $75,215.00 | 2019-2024 | Echelon Flex, Echelon Endopath, Harmonic |
| Atricure, INC. | $49,486.00 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medical Device Business Services, INC. | $40,336.37 | 2019-2024 | Echelon Flex, Echelon Endopath, Harmonic |
| Acumed LLC | $39,084.52 | 2019-2025 | Biobridge, Ribloc, Osteomed |
| Pacira Pharmaceuticals Incorporated | $10,640.95 | 2019-2021 | |
| Tela Bio, INC. | $8,516.17 | 2020-2022 | |
| Ethicon US, LLC | $8,135.18 | 2020-2025 | Vistaseal, Echelon Endopath, Dermabond |
| Medela Ag | $1,500.00 | 2022 | |
| Davol INC. | $634.88 | 2023-2025 | Progel Applicator Spray Tips, Tridyne Vascular Sealant, Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $525.01 | 2019-2025 | Airsupra |
| Intuitive Surgical, INC. | $514.71 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $363.83 | 2019-2024 | Keytruda |
| Medtronic, INC. | $295.27 | 2022-2024 | Signia |
| Aroa Biosurgery Incorporated | $225.84 | 2022-2023 | |
| Abbvie INC. | $174.65 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $157.88 | 2024-2025 | V.A.C. Granufoam, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| E.R. Squibb & Sons, L.L.C. | $152.79 | 2019-2022 | |
| Covidien LP | $147.70 | 2019 | |
| Osteomed LLC | $97.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $85.21 | 2019-2020 | |
| Amgen INC. | $62.01 | 2019 | |
| On Target Laboratories, INC | $60.29 | 2025 | Cytalux |
| Team 1, LLC | $37.39 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $30.42 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.12 | 2019 | |
| Janssen Biotech, INC. | $24.90 | 2021 | |
| Rigel Pharmaceuticals, INC. | $24.71 | 2019 | |
| Eisai INC. | $24.26 | 2019 | |
| Kci USA, INC. | $21.37 | 2023 | V.A.C.Instill, V.A.C. Veraflo Cleanse Choice, Prevena |
| Cook Medical LLC | $20.26 | 2020 | |
| Fortovia Therapeutics, INC. | $19.04 | 2019 | |
| Smith+Nephew, INC. | $17.81 | 2025 | Pico |
| Seagen INC. | $13.22 | 2021 | |
| Pfizer INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.